We also demonstrated significant differences in immunophenotype distribution and in leukemic stem cell frequencies suggesting that the progression of CML to blast phase could be linked to the LMPP-like stem cells whereas de novo BCR::ABL1+AML may stem in other hematopoietic progenitor compartments. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.